Does Amerigroup Cover Cialis?

How Amerigroup Formulary Coverage Works for Tadalafil

Amerigroup, a subsidiary of Elevance Health (formerly Anthem), operates Medicaid managed care and Affordable Care Act marketplace plans in more than 20 states. Each state plan maintains its own prescription drug formulary, which determines what medications are covered and at what cost tier. Generic tadalafil appears on the majority of Amerigroup state formularies because the FDA-approved generic versions (available since 2018 from manufacturers including Teva, Camber, and Ajanta) cost insurers roughly 95% less than brand Cialis did at peak pricing 1.

For Medicaid members, federal rules cap copays at nominal amounts. The Medicaid Drug Rebate Program requires that participating manufacturers provide rebates to state agencies, which incentivizes Amerigroup to include widely prescribed generics like tadalafil on preferred tiers 2. Brand-name Cialis, priced at roughly $450 to $500 for 30 tablets without insurance, is rarely placed on a preferred tier when an AB-rated generic exists.

You can verify your specific plan's formulary by logging into the Amerigroup member portal for your state or by calling the number on the back of your member ID card. Formulary documents are also publicly posted on each state's Amerigroup website under "Pharmacy" or "Prescription Drug Benefits."

Medicaid vs. Marketplace Plans: Key Differences

Coverage rules differ substantially depending on whether you hold an Amerigroup Medicaid card or an Amerigroup marketplace (exchange) plan. Medicaid members benefit from federal cost-sharing protections, while marketplace members face standard commercial plan structures with deductibles and coinsurance.

Under Medicaid, most states require Amerigroup to cover all FDA-approved drugs from manufacturers participating in the federal rebate program. A 2023 analysis from the Kaiser Family Foundation found that 49 states and D.C. covered at least one PDE5 inhibitor on their Medicaid preferred drug lists 3. Tadalafil, the most commonly prescribed PDE5 inhibitor for both erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), appears on nearly all of them.

Marketplace plan formularies are more restrictive. Amerigroup's ACA plans in states like Georgia, Texas, and New Jersey classify generic tadalafil as Tier 2 (preferred brand equivalent), with copays typically ranging from $10 to $25. Some Silver and Bronze plans apply a deductible to Tier 2 drugs, meaning you may pay full price until your deductible is met. Gold plans more often waive the deductible for generic medications.

Prior Authorization Requirements

Prior authorization (PA) is the most common barrier members encounter when trying to fill a Cialis or tadalafil prescription through Amerigroup. The PA process requires your prescriber to submit clinical documentation proving the medication is medically necessary before the pharmacy can dispense it.

For generic tadalafil prescribed for ED, many Amerigroup Medicaid plans do not require PA. However, some states (including Texas, Louisiana, and Tennessee) do impose PA for all ED medications regardless of generic status 4. The prescriber typically must document a confirmed diagnosis of erectile dysfunction, confirm that no contraindicated medications (particularly nitrates) are being used, and sometimes confirm that the member has tried a lower-cost alternative like sildenafil first.

Brand Cialis almost always requires PA across all Amerigroup plan types. The insurer's clinical criteria generally mandate that the member demonstrate an inadequate response to, or intolerance of, generic tadalafil before brand coverage is approved. This is consistent with standard formulary management practices described in the Academy of Managed Care Pharmacy's formulary guidance 5.

PA decisions are typically made within 24 to 72 hours. If denied, members have the right to appeal or request a formulary exception.

Tadalafil for BPH: A Separate Coverage Pathway

Tadalafil 5 mg daily is FDA-approved for the treatment of benign prostatic hyperplasia, both alone and in combination with ED 6. This BPH indication often follows a different coverage pathway within Amerigroup plans, and in many cases it is easier to obtain approval.

Because BPH is classified as a urological condition rather than a sexual health condition, some state Medicaid programs that restrict or limit ED drug coverage still provide full coverage for tadalafil prescribed for BPH. A 2019 retrospective cohort study of 4,132 men with BPH found that daily tadalafil 5 mg reduced International Prostate Symptom Score (IPSS) by an average of 5.6 points at 12 weeks, comparable to the improvement seen with tamsulosin 7.

If your prescriber writes the prescription with a BPH diagnosis code (ICD-10: N40.1), the claim may process without PA even in states where ED prescriptions require it. Your provider should include the appropriate diagnosis on the prescription and any supporting documentation showing lower urinary tract symptoms. The daily 5 mg dose is typically dispensed as a 30-count supply with one refill per month.

Quantity Limits and Step Therapy

Amerigroup imposes quantity limits on tadalafil for ED in nearly all plan configurations. These limits are designed to control costs and are consistent with the prescribing information.

For as-needed dosing (10 mg or 20 mg tablets), the standard quantity limit is 6 tablets per 30 days. Some Amerigroup plans allow up to 12 tablets per month, but this typically requires a quantity limit exception request from the prescriber. The FDA-approved dosing for as-needed use is 10 mg taken prior to anticipated sexual activity, with the option to increase to 20 mg or decrease to 5 mg based on efficacy and tolerability 6.

Step therapy is another utilization management tool Amerigroup may apply. A step therapy protocol requires that the member try and fail a preferred, lower-cost medication before the plan will cover the requested drug. For tadalafil, this usually means trying generic sildenafil first. Sildenafil is often placed on a lower formulary tier (Tier 1) because its average wholesale price is lower than tadalafil's. A comparative effectiveness review published in the Journal of Sexual Medicine analyzed 82 randomized controlled trials involving PDE5 inhibitors and found no statistically significant difference in overall efficacy between sildenafil, tadalafil, and vardenafil for ED, though tadalafil's 36-hour duration of action was a distinguishing clinical feature 8.

If your prescriber documents a clinical reason why sildenafil is not appropriate (for example, a preference for daily dosing, a need for longer duration of action, or a documented adverse reaction to sildenafil), the step therapy requirement can be overridden.

Expected Out-of-Pocket Costs

Your actual cost for tadalafil through Amerigroup depends on your plan type, state, pharmacy choice, and whether you have met your deductible (for marketplace plans).

Medicaid members in most states pay $0 to $3 per prescription for generic tadalafil. Federal Medicaid rules prohibit copays exceeding $4 for preferred generics for members below 150% of the federal poverty level 9. Some states eliminate copays entirely for Medicaid enrollees.

Marketplace members face wider cost variation. Based on publicly available Amerigroup formulary documents, generic tadalafil copays range from $5 on Gold plans to $25 on Bronze plans. If a deductible applies, the out-of-pocket cost before the deductible is met can range from $15 to $60 for a 30-day supply, depending on the pharmacy's contracted rate.

Using a preferred pharmacy consistently makes a measurable difference. Amerigroup's preferred pharmacy networks typically include CVS, Walgreens, and Walmart, where negotiated rates are lowest. Filling at a non-preferred pharmacy can increase your copay by 50% or more. Mail-order pharmacy options through Amerigroup's pharmacy benefit manager (often Express Scripts or CVS Caremark, depending on the state) may offer 90-day supplies at reduced per-unit costs.

For comparison, GoodRx data as of early 2026 shows generic tadalafil (30 tablets of 20 mg) priced between $12 and $45 at major retail pharmacies without insurance. In many cases, the cash price with a discount coupon is competitive with or lower than the insured copay, particularly for marketplace members who have not met their deductible.

How to Check Your Specific Amerigroup Coverage

The most reliable way to confirm your tadalafil coverage is a multi-step verification process. Do not rely solely on general formulary information, because Amerigroup's coverage can differ across states, plan types, and even between plan years.

Start by locating your plan's formulary document. Go to amerigroup.com, select your state, and manage to "Members" then "Pharmacy" or "Drug List." Download the most recent formulary PDF and search for "tadalafil." The listing will show the tier, any PA or step therapy requirements, and quantity limits.

Next, call Amerigroup's pharmacy helpline (the number is on your member ID card, typically on the back). Ask specifically: "Is generic tadalafil covered on my plan, and does it require prior authorization?" The representative can run a real-time benefits check that accounts for your specific plan configuration.

Your prescriber's office can also run an electronic prior authorization (ePA) through their practice management system. The CoverMyMeds platform, used by the majority of U.S. pharmacies and prescriber offices, supports ePA for Amerigroup plans and can return a coverage determination within minutes for straightforward requests 10.

If your claim is denied at the pharmacy, do not assume coverage is unavailable. Denials often result from missing diagnosis codes, quantity limit overages, or step therapy requirements that your prescriber can address with a simple phone call or PA submission.

Appealing a Denial or Requesting a Formulary Exception

Every Amerigroup member has the right to appeal a prescription drug denial. The appeals process is governed by federal regulations for both Medicaid and marketplace plans, and Amerigroup must respond within defined timelines.

For Medicaid plans, Amerigroup must issue a decision on a standard appeal within 30 days. Expedited appeals (for urgent medical situations) must be resolved within 72 hours. The member or prescriber can initiate the appeal by calling Amerigroup or submitting a written request. Supporting documentation should include the prescriber's clinical rationale, relevant lab results (such as testosterone levels if hypogonadism is a contributing factor), and documentation of any failed alternative therapies.

For marketplace plans, the external review process allows members to have an independent third party review the denial if the internal appeal is unsuccessful. The Affordable Care Act mandates that all marketplace plans provide access to external review 11.

A formulary exception request is a separate process from an appeal. It asks Amerigroup to cover a drug that is not on the formulary, or to cover it at a lower cost-sharing tier. The prescriber must provide a letter of medical necessity explaining why the requested medication (for instance, brand Cialis instead of generic tadalafil) is required for the specific patient. Common reasons include documented allergic reactions to inactive ingredients in generic formulations or treatment failure with the generic despite adequate dosing.

Tadalafil Efficacy: What the Evidence Shows

Understanding the clinical evidence behind tadalafil can help you have a more productive conversation with your prescriber and your insurance plan. PDE5 inhibitors remain the first-line pharmacotherapy for erectile dysfunction, as recommended by the American Urological Association (AUA) guidelines 12.

The original key trials for tadalafil demonstrated that 81% of men taking 20 mg as needed reported improved erections (measured by the Global Assessment Question) compared to 35% on placebo 13. A separate 12-week randomized trial of daily tadalafil 5 mg in 268 men with ED showed that 73.5% achieved erections sufficient for intercourse, versus 31.8% on placebo (P<0.001) 14.

For BPH, the CombAT-adjacent studies and the registration trials showed that tadalafil 5 mg daily produced statistically significant improvements in both IPSS total score and IIEF erectile function domain score simultaneously, making it the only approved oral medication that treats both conditions with a single tablet 6.

The AUA guidelines note: "PDE5 inhibitors are recommended as first-line therapy for patients with ED who are candidates for on-demand or daily pharmacotherapy" 12. This guideline-level recommendation strengthens any prior authorization or appeal submission to Amerigroup, because insurers are expected to cover guideline-concordant treatments.

Alternatives if Amerigroup Denies Tadalafil Coverage

If coverage is denied and your appeal is unsuccessful, several alternatives exist. Generic sildenafil (Viagra equivalent) is covered on virtually all Amerigroup formularies at the lowest tier, with copays of $0 to $5 for Medicaid members. Sildenafil 20 mg tablets, originally approved for pulmonary arterial hypertension under the brand name Revatio, are sometimes prescribed off-label for ED at higher doses and may process through insurance with fewer restrictions, though this approach requires prescriber familiarity with the dosing conversion 15.

Avanafil (Stendra) is another PDE5 inhibitor option, though it is typically placed on a higher formulary tier and costs more out of pocket. Vardenafil (Levitra equivalent) is available in generic form and may be covered as an alternative if tadalafil is restricted.

For members who prefer tadalafil specifically, manufacturer discount programs and pharmacy discount cards can reduce the cash price of generic tadalafil to as little as $10 to $15 for 30 tablets, potentially making it affordable even without insurance coverage. However, using a discount card means the purchase does not count toward your plan's deductible or out-of-pocket maximum.

Daily tadalafil 5 mg prescribed under a BPH diagnosis, as discussed earlier, may bypass ED-specific coverage restrictions entirely. If you have both BPH symptoms and ED, ask your prescriber whether this clinical pathway applies to your situation.